Get started
Work

Figure S7 from Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy

Year: 2023
Type: other
Abstract: The combination of Gemcitabine, Galunisertib, and anti-PD-1 does not significantly affect T-cell activation in the spleen
DOI: 10.1158/0008-5472.22423232.v1
Authors: Daniel R. Principe, Matthew Narbutis, Sandeep Kumar, Alex Park, Navin Viswakarma, Matthew J. Dorman, Suneel D. Kamath, Paul J. Grippo, Melissa L. Fishel, Rosa F. Hwang, Dinesh Thummuri, Patrick W. Underwood, Hidayatullah G. Munshi, Jose G. Trevino, Ajay Rana
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361898613
Cites:
Cited by:
Related to: 10